Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand-Reference-Cited by-同舟云学术

Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand

Published:2011-12-21 Issue:12 Volume:6 Page:e27837
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pitisuttithum Punnee,Rerks-Ngarm Supachai,Bussaratid Valai,Dhitavat Jittima,Maekanantawat Wirach,Pungpak Swangjai,Suntharasamai Pravan,Vanijanonta Sirivan,Nitayapan Sorachai,Kaewkungwal Jaranit,Benenson Michael,Morgan Patricia,O'Connell Robert J.,Berenberg Jeffrey,Gurunathan Sanjay,Francis Donald P.,Paris Robert,Chiu Joseph,Stablein Donald,Michael Nelson L.,Excler Jean-Louis,Robb Merlin L.,Kim Jerome H.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. HIV transmission rates in Thailand: evidence of HIV prevention and transmission decline.;LS Park;J Acquir Immune Defic Syndr,2010

2. Trends in three decades of HIV/AIDS epidemic in Thailand by nonparametric back calculation method.;N Punyacharoensin;AIDS,2009

3. Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand.;P Wirachsilp;Southeast Asian J Trop Med Public Health,2007

4. HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.;MA Arroyo;AIDS Res Hum Retroviruses,2010

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials and recent progress in HIV vaccine development;Functional & Integrative Genomics;2024-08-28

2. Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702;Vaccine;2024-08

3. The Question of HIV Vaccine: Why Is a Solution Not Yet Available?;Journal of Immunology Research;2024-04-08

4. Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV;Expert Review of Anti-infective Therapy;2023-02-27

5. Human Immunodeficiency Virus Vaccines;Plotkin's Vaccines;2023